RCR Industrial Flooring S.a.r.l. has been acquired by Serafin Group Ltd.
Columna Capital has sold RCR Industrial Flooring S.a.r.l. to Serafin Group Ltd.
RCR is a Spanish global player in the industrial flooring systems providing integrated solutions across applications (installation of high specification floors), products (resins, hardeners and steel joints), and consultancy services. The company’s blue-chip customer base comprises leading worldwide players in a wide range of industries such as retail, logistics, manufacturing, automotive and food. RCR is forecast to reach approximately US$187 million in sales in 2019.
Based in Germany, Serafin Group invests in established mid-sized companies with a business model that can be further improved by implementing operational and strategic measures. The Group has ten companies in its portfolio.
Columna Capital is an entrepreneurial investment firm with offices in London, Lugano and Luxembourg. Columna typically invests in profitable companies with revenues of US$17–110 million and is a long-term partner that bases its strategy on identifying unique opportunities with growth potential, with the aim of doubling the companies' size over the investment period.
Oaklins' team in Spain acted as the exclusive financial advisor to the shareholders of RCR, advising on the design, negotiations and closing. The Spanish team was supported by other Oaklins members to identify international investors. The team in Germany successfully contacted and helped close the transaction with Serafin Group.
Emilio Esteban
CEO, RCR Industrial Flooring, S.r.a.l.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more